We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

9 hedge funds and large institutions have $622K invested in Tenax Therapeutics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

80% more funds holding

Funds holding: 5 → 9 (+4)

0.01% more ownership

Funds ownership: 0.01% → 0.02% (+0.01%)

33% less capital invested

Capital invested by funds: $926K → $622K (-$304K)

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$374K
2
AC
Armistice Capital
New York
+$291K
3
Renaissance Technologies
Renaissance Technologies
New York
+$264K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$132K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$93.5K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$77K

TENX Hedge Fund Activity: Q4 2018 in Review

9 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2018, worth a combined $622K — down 33% from $926K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TENX positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $374K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $77K sold.

  • 9 institutional investors held Tenax Therapeutics (TENX) as of Q4 2018, up from 5 in Q3 2018.
  • Funds reported $622K of Tenax Therapeutics stock for Q4 2018, down 33% quarter-over-quarter.
  • 5 funds opened new Tenax Therapeutics positions in Q4 2018 and 1 closed out, a net change of +4 holders.
  • The largest Tenax Therapeutics buyer in Q4 2018 was Sabby Management, an estimated $374K added.
  • The largest Tenax Therapeutics seller in Q4 2018 was Dimensional Fund Advisors, an estimated $77K sold.

Based on aggregated 13F filings for Q4 2018.